title: [Percutaneous aortic valvuloplasty in the adult. When and why is now useful?].
abstract: Percutaneous aortic valvuloplasty was introduced into clinical practice in 1986 and widely applied in elderly patients with symptomatic aortic stenosis. Nevertheless its results have been unsatisfactory over the mid to long term due to a high incidence of restenosis after 6-12 months. At the same time, patients over 70 years are more frequently undergoing surgical aortic valve replacement with low immediate postoperative mortality and good long term results. Although randomized trials are not available, aortic valve replacement seems to be a definitive therapeutic treatment when compared to the palliative result of aortic percutaneous valvuloplasty. However, since the complication rate of valvuloplasty carried out in cardiological centers with experienced personnel is low, this procedure is still indicated in selected patients. The very old (> 80 years) patients with associated systemic disease, and candidates for major surgery are referred for this procedure. Another indication for aortic valvuloplasty is severe aortic stenosis with cardiogenic shock; in this case, valve dilatation improves clinical status and acts as a "bridge" to surgery, enabling surgical intervention to be carried out at a later date. Nowadays, aortic percutaneous valvuloplasty is a possible alternative to surgical treatment in patients with an absolute surgical contraindication and in those who are in such poor clinical condition that they cannot be immediately referred to surgery. It is also useful for patients requiring urgent non-cardiac surgery (e.g., subjects with gastrointestinal bleeding). We discuss our results with this procedure which concord with those presented in the literature.
authors.affiliation: Istituto di Malattie dell'Apparato Cardiovascolare, Università degli Studi di Bologha.
authors.forename: G
authors.initials: G
authors.lastname: Piovaccari
authors.forename: A
authors.initials: A
authors.lastname: Marzocchi
authors.forename: C
authors.initials: C
authors.lastname: Marrozzini
authors.forename: P
authors.initials: P
authors.lastname: Ortolani
authors.forename: T
authors.initials: T
authors.lastname: Palmerini
authors.forename: M
authors.initials: M
authors.lastname: Di Marco
authors.forename: S
authors.initials: S
authors.lastname: Di Luzio
authors.forename: M
authors.initials: M
authors.lastname: Ferlito
authors.forename: A
authors.initials: A
authors.lastname: Branzi
authors.forename: B
authors.initials: B
authors.lastname: Magnani
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D001024:Aortic Valve Stenosis / Q000628:therapy*; D004630:Emergencies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged
vernacular_title: La valvuloplastica aortica percutanea nell'adulto. Quando e per chi è ancora utile?.